Viralsol warning letter
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement Viralsol is an illegally marketed drug because it is intended to cure, mitigate, treat or prevent a disease, FDA says in a recent warning letter to the Yorba Linda, Calif.-based firm. FDA takes issue with claims that the product will "halt HIV infection in human cells," "suppress recurrence" of Hepatitis A, B and C, and mitigate herpes outbreaks and West Nile virus. The company does not list Viralsol's ingredients on the website where the supplement can be purchased, but states the product has "been shown to exhibit potent antiviral properties" against influenza and hemorrhagic fever viruses...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.